"The leaders of G20 member states will collaborate with UN's World Health Organization (WHO) and GAVI (Global Alliance for Vaccines and Immunizations) as well as other countries," she stated during an online press conference at the Bogor Presidential Palace, West Java.
Of the total US$4 billion, most will be allocated for funding research and developments.
"During a meeting (the G20 Sherpa extraordinary meeting) held a day before (the G20 extraordinary meeting), finance ministers of member states said US$4 billion will be collected from countries worldwide for the development of the COVID-19 vaccine. The ministers are currently discussing the details," Sri Mulyani expounded.
During the two meetings, the Indonesian government put forth five suggestions to world leaders to contain the spread of the novel coronavirus disease, or COVID-19.
Some of suggestions comprise a call to intensify protection of vulnerable groups, including the elderly, small and medium enterprises, and low-wage workers; ensure the safety of health workers serving at clinics and hospitals; facilitate the trade of vaccines as well as other medical equipment by easing tariffs on their import and export.
Related news: Protection of Indonesian nationals abroad remain topmost priority
Related news: World leadership reflected in G20 extraordinary meeting: official
Related news: Jokowi tells G20: Strengthen cooperation, check economic slowdown
Related news: G20 meeting: Indonesia offers suggestions on fighting coronavirus